Explore more publications!

Maryland Healthcare Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Maryland Healthcare Reporter.

Press releases published on March 19, 2026

Curia Memperluas Kapasitas Manufaktur Glasgow dan Meningkatkan Platform Pengembangan Lini Sel
Curia amplía la capacidad de fabricación en Glasgow y mejora su plataforma de desarrollo de líneas celulares
キュリア、グラスゴーの製造能力を拡大し、細胞株開発プラットフォームを強化
Curia Memperluas Kapasiti Pembuatan di Glasgow dan Mempertingkat Platform Pembangunan Garis Sel
Curia Expande Capacidade de Fabricação de Glasgow e Aprimora Plataforma de Desenvolvimento de Linhagem Celular
Curia ขยายขีดความสามารถในการผลิต ณ เมืองกลาสโกว์ พร้อมยกระดับแพลตฟอร์มการพัฒนาเซลล์ไลน์
Curia 扩大格拉斯哥产能并改进细胞系开发平台
Curia, 글래스고 생산 능력 확대 및 세포주 개발 플랫폼 고도화
Curia 擴充格拉斯哥製造產能並升級細胞系開發平台
Assembly Biosciences Reports Year-End 2025 Financial Results and Recent Highlights
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
Alumis Reports Year End 2025 Financial Results and Highlights Recent Achievements
electroCore Announces Full Year 2025 Financial Results and Organizational Changes
SELLAS Life Sciences Reports Full Year 2025 Financial Results and Provides Corporate Update
Rani Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results
Akebia Therapeutics to Host Virtual R&D Day Highlighting Robust Kidney Disease Pipeline, on April 2, 2026
Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results
Sangamo Therapeutics Announces Fourth Quarter and Full Year 2025 Earnings Call
SAB BIO Announces Closing of $85 Million Public Offering of Common Stock and Pre-Funded Warrants
Solésence To Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call on March 31, 2026

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions